Functional Neurological Disorder (FND) involves neurological symptoms arising from brain network changes rather than structural damage, often described as a “software” issue rather than a “hardware” problem. Symptoms…
Pompe disease is a progressive, life-threatening genetic neuromuscular disorder. Late-onset Pompe disease (LOPD), affecting individuals over one year old, leads to trunk and proximal muscle weakness, often impacting…
NEW YORK (Reuters Health) – Administration of an erythropoiesis-stimulating agent or ESA (in this case, darbepoietin) to patients with severe traumatic brain injury (STBI) improves survival without increasing…
NEW YORK (Reuters Health) – A transdermal sumatriptan formulation, NP101, in development for acute treatment of migraine, remains effective during a year of successive uses, according to a…
NEW YORK (Reuters Health) – When antiepileptic drug therapy fails to control disabling temporal lobe epilepsy adequately, patients have a much better chance of becoming seizure free with…
NEW YORK (Reuters Health) – Patients receiving rehabilitation for prolonged disorders of consciousness after severe traumatic brain injury show an accelerated pace of cognitive recovery when treated with…
NEW YORK (Reuters Health) – Abnormalities seen on brain CT with CT angiography (CTA) soon after a transient ischemic attack or minor stroke predict the risk of a…
NEW YORK (Reuters Health) – Dual rather than mono antiplatelet therapy started soon after ischemic stroke reduces the risk of recurrence without a significant increase in risk of…
NEW YORK (Reuters Health) – Patients with a recent non-cardioembolic ischemic stroke who are found to have a silent brain infarction (SBI) on MRI are not at significantly…
NEW YORK (Reuters Health) – Discontinuation of aspirin within 5 days of combined coronary artery bypass graft (CABG) and valve surgery is associated with an increased risk of…
NEW YORK (Reuters Health) – Pregabalin (Lyrica; Pfizer Inc) may help patients with fibromyalgia get a better night’s sleep, in addition to easing their pain, suggest results of…
NEW YORK (Reuters Health) – While respiratory stimulation with caffeine in very preterm infants with apnea of prematurity reduces rates of impairment at 18 months, the benefits are…
